21 resultados para 027:347.78
em Université de Lausanne, Switzerland
Resumo:
Résumé/Summary : La thèse présentée ici et intitulée The Vth prapāṭhaka of the Vādhūlaśrautasūtra consiste en une édition critique suivie d'une traduction et d'un commentaire du Ve chapitre (prapāṭhaka) du Vādhūlaśrautasūtra consacré au sacrifice animal dit "indépendant" (nirūḍhapaśubandha) de la religion védique. La traduction et le commentaire font l'objet du premier tome de cette thèse et l'édition critique celui du second tome. Le commentaire qui suit la traduction dans le premier tome ne se limite pas aux particularités de la version Vādhūla du nirūḍhapaśubandha. Il s'agit plutôt d'une série de monographies consacrées à des aspects particuliers du sacrifice animal décrit par les Veda, voire à des questions plus générales d'exégèse des textes védiques. Dans ma conclusion à la fin du premier tome je discute aussi de l'antiquité de l'école Vādhūla et de sa place dans le corpus textuel de la branche Taittirīya du Yajurveda noir. THE PRESENT THESIS, ENTITLED THE VTH PRAPAṭHAKA OF THE VADHULASRAUTASUTRA, CONSISTS IN A CRITICAL EDITION, FOLLOWED BY A TRANSLATION AND A COMMENTARY, OF THE VTH CHAPTER (PRAPAṭHAKA) OF THE VADHULASRAUTASUTRA. THE VTH PRAPAṭHAKA IS DEDICATED TO THE DESCRIPTION OF THE SO-CALLED "INDEPENDENT" ANIMAL SACRIFICE (NIRUḍHAPASUBANDHA) IN VEDIC RELIGION. THE TRANSLATION AND THE COMMENTARY ARE PRESENTED IN THE FIRST VOLUME, WHILE THE CRITICAL EDITION MAKES UP THE SECOND VOLUME. The commentary that follows the translation in the first volume is not concerned only with the peculiarities of the Vādhūla version of the nirūḍhapaśubandha. It is more a series of short monographs related to particular aspects of the animal sacrifice described in the Veda and to problems of exegesis of Vedic texts. In my conclusion at the end of the first volume, I also discuss the ancientness of the Vādhūla school, as well as its place within the corpus of Taittirīya texts.
Resumo:
Mutations in the CACNA1A gene, encoding the α1 subunit of the voltage-gated calcium channel Ca(V)2.1 (P/Q-type), have been associated with three neurological phenotypes: familial and sporadic hemiplegic migraine type 1 (FHM1, SHM1), episodic ataxia type 2 (EA2), and spinocerebellar ataxia type 6 (SCA6). We report a child with congenital ataxia, abnormal eye movements and developmental delay who presented severe attacks of hemiplegic migraine triggered by minor head traumas and associated with hemispheric swelling and seizures. Progressive cerebellar atrophy was also observed. Remission of the attacks was obtained with acetazolamide. A de novo 3 bp deletion was found in heterozygosity causing loss of a phenylalanine residue at position 1502, in one of the critical transmembrane domains of the protein contributing to the inner part of the pore. We characterized the electrophysiology of this mutant in a Xenopus oocyte in vitro system and showed that it causes gain of function of the channel. The mutant Ca(V)2.1 activates at lower voltage threshold than the wild type. These findings provide further evidence of this molecular mechanism as causative of FHM1 and expand the phenotypic spectrum of CACNA1A mutations with a child exhibiting severe SHM1 and non-episodic ataxia of congenital onset.
Resumo:
Right from the beginning of the development of the medical specialty of Physical and Rehabilitation Medicine (PRM) the harmonization of the fields of competence and the specialist training across Europe was always an important issue. The initially informal European collaboration was formalized in 1963 under the umbrella of the European Federation of PRM. The European Academy of PRM and the UEMS section of PRM started to contribute in 1969 and 1974 respectively. In 1991 the European Board of Physical and Rehabilitation Medicine (EBPRM) was founded with the specific task of harmonizing education and training in PRM in Europe. The EBPRM has progressively defined curricula for the teaching of medical students and for the postgraduate education and training of PRM specialists. It also created a harmonized European certification system for medical PRM specialists, PRM trainers and PRM training sites. European teaching initiatives for PRM trainees (European PRM Schools) were promoted and learning material for PRM trainees and PRM specialists (e-learning, books and e-books, etc.) was created. For the future the Board will have to ensure that a minimal specific undergraduate curriculum on PRM based on a detailed European catalogue of learning objectives will be taught in all medical schools in Europe as a basis for the general medical practice. To stimulate the harmonization of national curricula, the existing postgraduate curriculum will be expanded by a syllabus of competencies related to PRM and a catalogue of learning objectives to be reached by all European PRM trainees. The integration of the certifying examination of the PRM Board into the national assessment procedures for PRM specialists will also have to be promoted.
Resumo:
L'étude comparative de deux traductions de « Cendrillon ou la petite pantoufle de verre » de Charles Perrault montre comment le conte est réorienté vers la jeunesse en Angleterre à partir de projets très différents. «Cinderilla: or, The Little Glass Slipper», publié par Robert Samber dans Histories, or Tales of Past Times. With Morals en 1729, est considéré comme la première traduction du conte en langue anglaise. Plus près de nous, sa retraduction par l'écrivain britannique Angela Carter, « Cinderella: or, The Little Glass Slipper », parue dans The Fairy Tales of Charles Perrault en 1977, donne une nouvelle actualité au conte de Perrault. La première traduction propose un calque du conte qui illustre les conditions matérielles et l'interdiscours des traducteurs de Grub Street au début du XVIIIe siècle, tandis que la deuxième adapte le conte pour les enfants dans une perspective féministe au XXe siècle. Mon analyse s'attache surtout à dégager les enjeux de la (re)traduction de Carter, qui se démarque délibérément de Samber pour renouveler le sens du conte de Perrault et de sa morale.
Resumo:
Mutations in the CACNA1A gene, encoding the α1 subunit of the voltage-gated calcium channel CaV2.1 (P/Q-type), have been associated with three neurological phenotypes: familial and sporadic hemiplegic migraine type 1 (FHM1, SHM1), episodic ataxia type 2 (EA2), and spinocerebellar ataxia type 6 (SCA6). We report a child with congenital ataxia, abnormal eye movements and developmental delay who presented severe attacks of hemiplegic migraine triggered by minor head traumas and associated with hemispheric swelling and seizures. Progressive cerebellar atrophy was also observed. Remission of the attacks was obtained with acetazolamide. A de novo 3bp deletion was found in heterozygosity causing loss of a phenylalanine residue at position 1502, in one of the critical transmembrane domains of the protein contributing to the inner part of the pore. We characterized the electrophysiology of this mutant in a Xenopus oocyte in vitro system and showed that it causes gain of function of the channel. The mutant CaV2.1 activates at lower voltage threshold than the wild type. These findings provide further evidence of this molecular mechanism as causative of FHM1 and expand the phenotypic spectrum of CACNA1A mutations with a child exhibiting severe SHM1 and non-episodic ataxia of congenital onset.
Resumo:
OBJECTIVE: To examine the occurrence of arthrogryposis multiplex congenita (AMC) in Europe and to identify possible risk factors. STUDY DESIGN: Retrospective population-based epidemiological study using EUROCAT congenital anomaly registries. The study population included all cases of AMC (based on WHO ICD-9 or ICD-10 codes) that were livebirths (LB), fetal deaths (FD) from 20 weeks gestation and underwent termination of pregnancy for fetal anomaly (TOPFA), 1980-2006. RESULTS: Among 8.9 million births covered by 24 EUROCAT congenital anomaly registries, 757 AMC cases were reported. This gives a prevalence of 8.5 per 100,000. Five hundred and four (67%) AMC cases were LB, 199 (26%) cases were TOPFA, and FD occurred in 54 (7%) cases. First week survival status was known for 381 of the 504 LB (76%), of whom 87 (23%) died within the first week of life. Perinatal mortality associated with AMC was 32%. Two hundred and eighty-two (37%) cases had isolated AMC, 90 (12%) had additional syndrome or chromosomal anomalies and 385 (51%) had other major malformations. The same or similar anomaly was reported in 13% of siblings and in 12% of the mother's own family background. Information on prenatal testing was available for 521 cases of which 360 tested positive for a congenital anomaly, representing a sensitivity of 69%. Information on maternal illness before and during pregnancy and medication use in the first trimester was available for approximately a third of the mothers, of whom the vast majority reported no maternal illness or medication use. CONCLUSION: AMC is a rare occurrence, with a reported prevalence of 1:12,000. In this study, while information on potential risk factors such as maternal disease or maternal use of drugs was limited, they did not appear to be associated with the occurrence of AMC. AMC was lethal in a third of cases, either in utero or during the first week of life, although this may not be solely attributed to AMC as most cases had additional malformations.